News
GPs will be prescribing Mounjaro to a select few people as the rollout begins, but others may need to avoid the jabs ...
Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...
The new weight loss drug which is set to give Ozempic and Mounjaro a run for their money, MariTide, is taken on a monthly ...
With Mounjaro being rolled out at GPs down south, experts have listed the reasons why people getting the jabs may still not ...
Around a fifth of users report not losing the expected amounts of weight on Mounjaro, and doctors have some answers ...
12d
News-Medical.Net on MSNOnce-monthly obesity injection shows double-digit weight loss in major clinical trialResearchers found that once-monthly maridebart cafraglutide led to substantial weight loss and improved glycemic control in ...
Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with ...
Thousands are now eligible to get Mounjaro through the NHS, but some may need to avoid it and it might not even work for others ...
13d
MedPage Today on MSNNovel GLP-1/GIP Agent Led to Weight Loss With Once-Monthly DosingCHICAGO -- An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in ...
13d
News-Medical.Net on MSNAmycretin delivers unprecedented weight loss in early trial for obesity treatmentOnce-weekly amycretin, a novel peptide activating GLP-1, amylin, and calcitonin receptors, produced rapid, substantial, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results